Literature DB >> 7963553

Regulation of MCP-1/JE gene expression during monocytic differentiation.

H J Gruss1, M A Brach, R R Schumann, F Herrmann.   

Abstract

We examined the expression of the MCP-1/JE gene in freshly prepared human monocytes and again after either in vitro or in vivo maturation of these cells. We show that previously unstimulated blood monocytes of healthy individuals prepared by adherence procedures display high levels of MCP-1/JE mRNA and protein. Monocytes that were not previously exposed to activational plastic surfaces but were separated from other blood cells by counter-flow centrifugal elutriation expressed severalfold lower MCP-1/JE transcript and protein levels. Treatment of these cells with endotoxin was associated with the down-regulation of MCP-1/JE mRNA and protein levels. In contrast, exposure to IFN-gamma resulted in increased MCP-1/JE gene expression. During the process of in vitro maturation of monocytes into macrophages, a gradual decrease of MCP-1/JE mRNA and protein expression was noted. Both mature (day 8) blood monocyte-derived culture macrophages and peritoneal macrophages completely failed to express the MCP-1/JE gene, which could be restored after exposure to IFN-gamma and cross-linking of macrophage Fc gamma R with murine solid phase IgG2a mAbs; however, endotoxin failed to induce MCP-1/JE expression in these cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963553

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  Retinoic acid and tumor necrosis factor-α induced monocytic cell gene expression is regulated in part by induction of transcription factor MafB.

Authors:  Y Zhang; Q Chen; A C Ross
Journal:  Exp Cell Res       Date:  2012-07-20       Impact factor: 3.905

2.  Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines.

Authors:  W J Karpus; K J Kennedy; S L Kunkel; N W Lukacs
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.